Literature DB >> 23377322

Palmoplantar pustulosis with fulminant dystrophic 20-nail psoriasis in a patient receiving adalimumab therapy.

Vineet Mishra, Ralph C Daniel, Craig A Elmets, Anna Levin, Boni E Elewski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23377322      PMCID: PMC3971542     

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


× No keyword cloud information.
  5 in total

1.  Grading simple chronic paronychia and onycholysis.

Authors:  C Ralph Daniel; Matilde Iorizzo; Bianca Maria Piraccini; Antonella Tosti
Journal:  Int J Dermatol       Date:  2006-12       Impact factor: 2.736

2.  Palmoplantar and scalp psoriasis occurring during anti-tumour necrosis factor-alpha therapy: a case series of four patients and guidelines for management.

Authors:  E Papadavid; S Gazi; M Dalamaga; N Stavrianeas; V Ntelis
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-03       Impact factor: 6.166

3.  Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction.

Authors:  P P Sfikakis; A Iliopoulos; A Elezoglou; C Kittas; A Stratigos
Journal:  Arthritis Rheum       Date:  2005-08

Review 4.  Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients.

Authors:  Uwe Wollina; Gesina Hansel; André Koch; Jaqueline Schönlebe; Erich Köstler; Gunter Haroske
Journal:  Am J Clin Dermatol       Date:  2008       Impact factor: 7.403

5.  Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments.

Authors:  J Seneschal; B Milpied; B Vergier; S Lepreux; T Schaeverbeke; A Taïeb
Journal:  Br J Dermatol       Date:  2009-06-05       Impact factor: 9.302

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.